Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival

Iris J M Levink, Lodewijk A A Brosens, Sander S Rensen, Merel R Aberle, Steven S W Olde Damink, Djuna L Cahen, Sonja I Buschow, Gwenny M Fuhler, Maikel P Peppelenbosch, Marco J Bruno

Research output: Contribution to journalArticleAcademicpeer-review

2 Downloads (Pure)

Abstract

Introduction: Factors underlying antitumor immunity in pancreatic cancer (PC) are poorly understood. We hypothesized that not neoantigen quantity, but quality, is related to immune cell infiltration and survival. Methodology: We performed genomic and transcriptomic profiling of paired normal, tumor tissue of 13 patients with PC with distinct survival times. Additionally, neoantigens prediction and immunological profiling were performed. Results: The proportion of neoantigens with a low similarity-to-self score was higher in short-term survivors (p < 0.0001), while mutational load and burden, similarity-to-known-pathogens, and immunogenicity of neoantigens were not associated with immune cell infiltration or survival. Discussion: No tumor mutational load or neoantigen quantity, but low similarity-to-self score, was associated with immune cell infiltration and survival.

Original languageEnglish
Article number751110
Pages (from-to)1-7
JournalFrontiers in medicine
Volume8
DOIs
Publication statusPublished - 9 Feb 2022

Keywords

  • cancer immunity
  • chromosomal instability disorders
  • mutation–genetics
  • neoantigen and shared-antigen vaccine
  • pancreatic cancer

Fingerprint

Dive into the research topics of 'Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival'. Together they form a unique fingerprint.

Cite this